Ligand id: 4826

Name: ouabain

Structure and Physico-chemical Properties

2D Structure
Calculated Physico-chemical Properties
Hydrogen bond acceptors 12
Hydrogen bond donors 8
Rotatable bonds 4
Topological polar surface area 206.6
Molecular weight 584.28
XLogP -0.81
No. Lipinski's rules broken 2

Molecular properties generated using the CDK

No information available.
Summary of Clinical Use
Used in the treatment of atrial fibrillation, atrial flutter and heart failure. According to the US FDA International Drug Names listing, this drug is only available in Taiwan and Germany.
Mechanism Of Action and Pharmacodynamic Effects
Inhibition of the cardiac Na+-K+-ATPase membrane pump, results in an increase in intracellular sodium and calcium concentrations. Increased intracellular calcium concentrations may be responsible for the activation of contractile proteins in the heart.